Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Amgen Faces Data Breach Investigation

Guavy AI Editorial Team
Instruments
AMGN
Share

California-based biotechnology company Amgen Inc. is under investigation for a data breach that occurred in July 2026.

The breach, which was disclosed in an SEC Form 8-K filing, allowed unauthorized access to sensitive information of individuals affiliated with the company.

Amgen described the data breach as 'material' but did not disclose the number of individuals impacted.

The compromised data may include proprietary information, patient protected health information, and other sensitive details.

More on Stocks

Stocks 1m ago

Windows 11 Telemetry Process Sparks Controversy and Fears of 'Spying'

Stocks 1m ago

OCOOPA Hand Warmers Recalled Amid Reports of Fires, Burn Injuries, and Wrongful Death Lawsuit

Stocks 2m ago

Williamsport Resident Donald Leroy Miller Passes Away at 88

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy